# Recordkeeping and Reporting Requirements for Drug Products Containing Gamma-Hydroxybutyric Acid (GHB)
> **Rule** · Final rule. · Published 2005-01-04 · 70 FR 291
## Document
- **Document number:** 05-56
- **Category:** other
- **Type:** Rule
- **Action:** Final rule.
- **Citation:** 70 FR 291
- **Publication date:** 2005-01-04
## Abstract

DEA is amending its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA makes these changes under section 4 of the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000." These additional requirements are necessary to protect against the diversion of GHB for illicit purposes.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2005/01/04/05-56/recordkeeping-and-reporting-requirements-for-drug-products-containing-gamma-hydroxybutyric-acid-ghb)
---
*AI Analytics · CC0 1.0*